Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
PUBLIC WORKS AND GOVERNMENT SERVICES CANADA has floated a tender for Duodote Autoinjector (W6369-23A004/A). The project location is Canada and the tender is closing on 15 Jul 2022. The tender notice number is W6369-23A004/A, while the TOT Ref Number is 68414746. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Canada
Summary : Duodote Autoinjector (W6369-23A004/A)
Deadline : 15 Jul 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 68414746
Document Ref. No. : W6369-23A004/A
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Tender are invited for Trade Agreement: CETA/WTO-AGP/CPTPP/CFTA/FTAs with Peru/Colombia/Panama/Korea/UKTendering Procedures: Generally only one firm has been invited to bidNon-Competitive Procurement Strategy: Exclusive RightsComprehensive Land Claim Agreement: NoVendor Name and Address: Meridian Medical Technologies, Inc.6350 Stevens Forest RoadSuite 301Columbia MarylandUnited States21046Nature of Requirements: 1. Definition of the requirement The Department of National Defence (DND) has a requirement for the supply of a dual autoinjector containing atropine and pralidoxime chloride to provide treatment of intoxication resulting from suspected exposure to chemical nerve agents or poisoning by a pesticide. 2. Criteria for assessment of the Statement of Capabilities (Minimum Essential Requirements) Any interested supplier must demonstrate by way of a statement of capabilities that its product meets the following requirements: a) The product must have regulatory approval from the US Food and Drug Administration (FDA) or Health Canada.b) The product must have an indication for the treatment of poisoning/intoxication resulting from exposure to organophosphorus nerve agents.c) The product must come in a self-contained single use autoinjector device capable of administering an intramuscular dose.d) Each autoinjector must contain 2.1mg atropine and 600mg pralidoxime chloride.e) All packaging of the product must be labelled in accordance with the direction of the approving regulatory...
Documents
Procurement Documents for Canada
Access a comprehensive library of standard procurement documents specific to Canada. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Canada
Want To Bid in This Tender?
Get Local Agent Support in Canada and 60 More Countries.
View Tenders By
Sign in with Google